Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 24 (5), 774-782
- https://doi.org/10.1016/s0741-5214(96)70012-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Reporting standards in venous disease: An updateJournal of Vascular Surgery, 1995
- Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysisBMJ, 1994
- Deep venous thrombosis and the risk of pulmonary embolism. A systematic study.Chest, 1992
- Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the legThrombosis Research, 1992
- Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- An Open Trial of Enoxaparin in the Treatment of Deep Vein Thrombosis of the LegPathophysiology of Haemostasis and Thrombosis, 1991
- Clinical Validity of a Normal Perfusion Lung Scan in Patients with Suspected Pulmonary EmbolismChest, 1990
- Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersThrombosis Research, 1986
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979
- Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasmaThrombosis Research, 1979